Tradestie Institutional Equity Comparison Engine

ABBNY vs EMR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EMR Overall Edge

EMR Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Emerson Electric Co. (EMR) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, ABBNY trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus EMR at 22.9x Forward P/E and 24.8% operating margin (+7.1% YoY). In options structure, ABBNY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against EMR sits in CONSOLIDATION (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EMR
ABBNY N/M vs EMR 22.9x Fwd P/E
Growth & Margin Winner EMR
Op Margin N/A vs 24.8% ยท YoY N/A vs +7.1%
Momentum & Technical Winner EMR
1Y +16.4% vs +25.4% ยท 52W Pos 38% vs 78%
Options & Structure Winner EMR
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (6th %ile IV)
ABBNY US Equity
ABBNY
Institutional Equity
$83.75
+0.01% 1D
Market Cap N/A
1M Return -9.64%
1Y Return +16.43%
Forward P/E N/M
Unified AI Score
55.7 / 100 HOLD
Tech 83.0 Fund 56.0 Flow 50.0 Mom 50.0
EMR NYSE
Emerson Electric Co.
Electronic & Other Electrical Equipment (No Computer Equip)
$161.06
-3.2% 1D
Market Cap $91.6B
1M Return -0.25%
1Y Return +25.38%
Forward P/E 22.9x
Unified AI Score
51.2 / 100 HOLD
Tech 40.0 Fund 48.0 Flow 59.0 Mom 45.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: ABBNY +16.43% EMR +25.38% Spread: +10.69 pp (EMR Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
ABBNY TTM Op. Margin: N/A EMR TTM Op. Margin: 24.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ABBNY vs EMR. Trailing 12-month operating profitability (ABBNY N/A vs EMR 24.8%) and valuation multiples (ABBNY N/M vs EMR 22.9x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: ABBNY (1) vs EMR (9)
Institutional Metric ABBNY EMR Criterion Row Winner
Market Capitalization Scale N/A $91.6B Larger Scale EMR
Trailing P/E Ratio Valuation N/M 34.9x Lower Multiple EMR
Forward P/E Ratio Valuation N/M 22.9x Lower Multiple EMR
Revenue Growth (YoY) Growth N/A +7.1% Higher Growth EMR
Operating Margin (TTM) Profitability N/A 24.8% Higher Margin EMR
Net Profit Margin Profitability N/A 14.2% Higher Margin EMR
Return on Equity (ROE) Capital Efficiency N/A 13.1% Higher ROE EMR
52-Week Range Position Momentum 38% ($67โ€“$110) 78% ($123โ€“$172) Stronger Trend EMR
Beta / 30D Volatility Risk Regime 1.81ฮฒ ยท 41% Vol 1.45ฮฒ ยท 34% Vol Lower Realized Risk EMR
Unified Institutional Score Composite Signal 55.7 / 100 (HOLD) 51.2 / 100 (HOLD) Higher Composite ABBNY

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full ABBNY vs EMR Buy Guide
ABBNY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live ABBNY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
EMR CONSOLIDATION
68d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live EMR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither ABBNY nor EMR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.